Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Indraprastha Medical Corporation Ltd (INDRAMEDCO) is currently trading at 362.20 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Indraprastha Medical Corporation Limited provides high-quality, comprehensive hospital services, enhancing patients' quality of life. The company has established India's first corporate hospital, a multi-disciplinary super-speciality tertiary care hospital in New Delhi. Recent advancements include robotic surgeries, complex transplants, and unique procedures like 3D-assisted surgeries and innovative cancer treatments. The hospital continues to innovate, highlighted by breakthroughs like the first robotic hip replacement in North India and Zap-X radiosurgery. A strong focus on infrastructure enhancements and patient experience is evident, with several new clinical services and significant technology investments.
Over the past 52 weeks, Indraprastha Medical Corporation Ltd has traded between a low of ₹342.35 and a high of ₹640.05. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Indraprastha Medical Corporation Ltd has a market capitalization of approximately 3,326.35. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Indraprastha Medical Corporation Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 17.69 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 3,326.35 Cr, Indraprastha Medical Corporation Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Indraprastha Medical Corporation Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Indraprastha Medical Corporation Ltd is 17.69. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The board meeting is scheduled for Tuesday, May 12, 2026.
Bearish
4
Neutral
7
Bullish
3
Bearish
20
Neutral
7
Bullish
19
Bearish
16
Neutral
0
Bullish
16
Discovery themes featuring this stock
Indraprastha Medical Corporation Limited provides high-quality, comprehensive hospital services, enhancing patients' quality of life.
The company has established India's first corporate hospital, a multi-disciplinary super-speciality tertiary care hospital in New Delhi.
Recent advancements include robotic surgeries, complex transplants, and unique procedures like 3D-assisted surgeries and innovative cancer treatments.
The hospital continues to innovate, highlighted by breakthroughs like the first robotic hip replacement in North India and Zap-X radiosurgery.
A strong focus on infrastructure enhancements and patient experience is evident, with several new clinical services and significant technology investments.
Bearish
4
Neutral
7
Bullish
3
Bearish
4
Neutral
7
Bullish
3
Bearish
16
Neutral
0
Bullish
16
Bearish
16
Neutral
0
Bullish
16
Bearish
16
Neutral
0
Bullish
16
Healthcare Services
Hospital
3,326 Cr
High Risk
17.7
65.3
1.7
4.5
640.05
342.35
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
338.00 | 5,358 Cr | 47.02 | 6.19 | 0.13 | 11.09 | 13.95 | 7.98 | ||
362.20 | 3,326 Cr | 17.69 | 4.49 | 1.10 | 24.80 | 32.39 | 18.96 | ||
5380.00 | 2,598 Cr | 34.09 | 7.50 | 0.07 | 20.24 | 15.63 | 9.94 | ||
153.00 | 2,453 Cr | 43.98 | 11.66 | 0.00 | 22.21 | 24.22 | 16.79 | ||
138.00 | 1,489 Cr | 39.69 | 1.48 | 0.00 | 3.72 | 6.20 | 2.04 | ||
183.00 | 1,432 Cr | 85.53 | 5.67 | 0.00 | 6.14 | 8.20 | 5.62 | ||
165.75 | 1,361 Cr | 28.80 | 5.05 | 1.51 | 15.67 | 16.97 | 10.17 | ||
| Median: 7 Co. | — | 183.00 | 2,453 Cr | 39.69 | 5.67 | 0.07 | 15.67 | 15.63 | 9.94 |
